Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06571799 · ClinicalTrials.gov registry record · NA
Study Evaluating the Efficacy and Safety of BENEV Exosome Regenerative Complex+ for Self-perceived Thinning Hair
A NA study of Thinning Hair, sponsored by Ablon Skin Institute Research Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06571799 is a NA study of Thinning Hair that has completed, run by Ablon Skin Institute Research Center. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06571799, a NA study of Thinning Hair, has completed, sponsored by Ablon Skin Institute Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to further substantiate the effectiveness and safety of BENEV Exosome Regenerative Complex+ post SylFirmX® RF microneedling procedure for self-perceived thinning hair in healthy men and women ages 18-65 over the course of four months. Participants will be asked to have treatments monthly for 4 sessions, attend a follow up appointment 4 weeks after the 4th session, have photos taken of their hair and answer questionnaires related to their thinning hair.
Conditions Studied
Interventions
- OTHER BENEV Exosome Regenerative Complex+
Study Locations (1)
California
- Ablon Skin Institute & Research Center - Manhattan Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-09-03 |
| Est. Completion | 2025-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06571799
The ClinicalTrials.gov registry entry for NCT06571799 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ablon Skin Institute Research Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thinning Hair appearing as the primary indexed condition, and to 1 intervention - of which BENEV Exosome Regenerative Complex+ is the first listed.
NCT06571799 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06571799 about?
NCT06571799 is a clinical study titled "Study Evaluating the Efficacy and Safety of BENEV Exosome Regenerative Complex+ for Self-perceived Thinning Hair". The goal of this clinical trial is to further substantiate the effectiveness and safety of BENEV Exosome Regenerative Complex+ post SylFirmX® RF microneedling procedure for self-perceived thinning hair in healthy men and women ages 18-65 over the course of four months. Participants will be asked to ...
What is the current status of trial NCT06571799?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2024-09-03. Estimated completion is 2025-03-27.
What conditions does trial NCT06571799 study?
This clinical trial studies the following conditions: Thinning Hair.
What interventions are being tested in trial NCT06571799?
The interventions under investigation include: BENEV Exosome Regenerative Complex+ (OTHER).
Who is sponsoring clinical trial NCT06571799?
This trial is sponsored by Ablon Skin Institute Research Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06571799 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thinning Hair
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.
ACTIVE NOT RECRUITING · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.